Opocrin Group will attend DCAT 2026, taking place in New York City from March 23 to 25, one of the leading international gatherings for companies operating across the bio-pharmaceutical manufacturing value chain.
DCAT provides a strategic opportunity to engage with industry stakeholders, exchange perspectives on market developments, and explore collaboration opportunities across the supply chain. As a global player active in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and integrated pharmaceutical solutions, Opocrin Group looks forward to strengthening existing partnerships and building new connections.
To arrange a meeting with our team during DCAT, please contact: info@opocrin.it
